SOMATOTROPIN THERAPY IN GROWTH HORMONE DEFICIENT CHILDREN

生长激素缺乏儿童的生长激素治疗

• 批准号: 3886224
• 负责人: JO ANNE BRASEL
• 金额: --
• 依托单位: LOS ANGELES COUNTY HARBOR-UCLA MED CTR
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3886224
• 关键词: blood chemistry; child (0-11); clinical trials; hormone therapy; human subject; human therapy evaluation; postnatal growth disorder; somatotropin

To determine if a new biosynthetic human growth hormone is a safe and effective treatment for children with growth hormone deficiency. Linear growth measurement, bone age and blood chemistries will be obtained every three months to evaluate the effectiveness of the treatment.

确定一种新的生物合成人类生长激素是否安全 儿童生长激素的有效治疗 不足。 线性生长测量、骨龄和血液 每三个月进行一次化学分析以评估 治疗的有效性。